Therapy for Stage IV Non-Small Cell Lung Canc...

Dr. Sonam Puri discusses the full update to the living guideline on stage IV NSCLC with driver alterations. She shares a new overarching recommendation on biomarking testing and explains the new recommendations and the supporting evidence for first-line and subsequent therapies f ...  Show more

Dr. Joshua Reuss is back on the podcast to discuss the full update to the living guideline on stage IV NSCLC without driver alterations. He discusses the new evidence and how this impacts the latest recommendations on first-line and subsequent therapeutic options. Dr. Reuss empha ...  Show more

<span style="font-size: 12pt;">Modern-day evidence-based medicine mandates a strong understanding of current local and international guidelines. Surgeons rely heavily on these reports, but what to do when they differ? We have partnered with the ESVS podcast in creati ...

Join the Surgical Oncology team from UTSouthwestern and the University of Miami as they tackle a journal review covering how to choose perioperative antimicrobial prophylaxis for pancreatoduodenectomy. Listen in as they also review novel methodology and the origins of the study.L ...  Show more

Fill up with delicious practice-changing knowledge food from #SGIM22 as The Curbsiders team discusses breast cancer survivorship, sexual dysfunction, How climate change will affect health, Are PT consults necessary in the hospital?, Do we need antibiotics for aspiration events?, ...  Show more

Quelle voie d’abord privilégier ? Faut-il faire une exérèse de l’uretère distal ?Faut-il faire une ligature première de l’uretère ?Faut-il faire un curage ganglionnaire ? Faut-il faire une IPOP ?Le Dr Xylinas (CHU Bichat, Paris) répond à toutes vos questions ! L’orateur n’a pas r ...  Show more